Linked Data API

Show Search Form

Search Results

1024687
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Rare Diseases: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that there is no disparity in access to treatments for rare diseases between the UK and economically similar countries in Europe. more like this
tabling member constituency Newton Abbot more like this
tabling member printed
Anne Marie Morris more like this
uin 202087 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>The Government is committed to the safe and effective regulation of medicines in the United Kingdom; ensuring patients and the public have fast access to new, innovative medicines, including medicines for rare diseases.</p><p> </p><p>The agreement of an implementation period will ensure that access to medicines continues, and patient safety is maintained, in both the UK and European Union markets. Beyond that, the Political Declaration sets out a plan for a free trade area for goods, underpinned by deep regulatory co-operation, as well as a joint commitment to explore close cooperation with the European Medicines Agency.</p><p> </p><p>The Government also continues to prepare for the unlikely outcome that we leave the EU without any deal in March 2019. The Department has been engaging with all pharmaceutical companies that supply the United Kingdom with pharmacy or prescription-only medicines from, or via, the EU/European Economic Area, on their contingency plans in the event of a no deal EU exit.</p><p> </p><p>Whatever the exit scenario, we will continue to ensure that UK patients are able to access the best and most innovative medicines including medicines for rare diseases and that their safety is protected.</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2018-12-18T17:36:24.12Zmore like thismore than 2018-12-18T17:36:24.12Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
4249
label Biography information for Anne Marie Morris more like this
1024696
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading North Staffordshire Combined Healthcare NHS Trust more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text o ask the Secretary of State for Health and Social Care, what correspondence he has received from (a) local authorities in Staffordshire and (b) the Midlands Partnership Foundation Trust on the future of the North Staffordshire Combined Healthcare Trust; and if he will place a copy of such correspondence in the Library. more like this
tabling member constituency Stoke-on-Trent Central more like this
tabling member printed
Gareth Snell more like this
uin 202089 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>The Department has received one item of relevant correspondence from a local authority in Staffordshire, which is attached. There has been no correspondence from the Midlands Partnership Foundation Trust on the future of the North Staffordshire Combined Healthcare Trust.</p> more like this
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
question first answered
less than 2018-12-18T17:00:30.493Zmore like thismore than 2018-12-18T17:00:30.493Z
answering member
1585
label Biography information for Stephen Hammond more like this
attachment
1
file name Staffs County Council.pdf more like this
title Letter Staffs County Council more like this
tabling member
4595
label Biography information for Gareth Snell more like this
1024698
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Orphan Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether he is taking steps to introduce a revised definition for ultra-orphan medicine. more like this
tabling member constituency Linlithgow and East Falkirk more like this
tabling member printed
Martyn Day more like this
uin 202090 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-20more like thismore than 2018-12-20
answer text <p>Currently, rare diseases are defined as conditions affecting no more than five in 10,000 people in the European Union. The new European Clinical Trial Regulation (Regulation (EU) No 536/2014) will introduce an ‘ultra-rare’ condition and states that clinical trials for the development of orphan medicinal products and those of medicines affecting no more than one person in 50,000 in the EU (ultra-rare diseases) should be fostered, and in such areas, a rapid yet in-depth assessment is of particular importance. The new clinical trials regulation is expected to be implemented in the EU in late 2020. The Government has confirmed that United Kingdom law will remain aligned with the parts of the new EU clinical trials Regulation that are within the UK’s control.</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2018-12-20T17:10:46.507Zmore like thismore than 2018-12-20T17:10:46.507Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
4488
label Biography information for Martyn Day more like this
1024700
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Rare Diseases: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the UK remains a world leader for the treatment of rare diseases after the UK leaves the EU. more like this
tabling member constituency Linlithgow and East Falkirk more like this
tabling member printed
Martyn Day more like this
uin 202091 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-20more like thismore than 2018-12-20
answer text <p>The Government is committed to the safe and effective regulation of medicines in the United Kingdom; ensuring patients and the public have fast access to new, innovative medicines, including medicines for rare diseases.</p><p> </p><p>The agreement of an implementation period will ensure that access to medicines continues, and patient safety is maintained, in both the UK and European Union markets. Beyond that, the Political Declaration sets out a plan for a free trade area for goods, underpinned by deep regulatory co-operation, as well as a joint commitment to explore close cooperation with the European Medicines Agency.</p><p> </p><p>The Government also continues to prepare for the unlikely outcome that we leave the EU without any deal in March 2019. The Department has been engaging with all pharmaceutical companies that supply the United Kingdom with pharmacy or prescription-only medicines from, or via, the EU/European Economic Area, on their contingency plans in the event of a no deal EU Exit.</p><p> </p><p>Whatever the exit scenario, we will work to ensure that the UK will remain a world leader for the treatment of rare diseases after the UK leaves the EU, that UK patients are able to access the best and most innovative medicines including medicines for rare diseases and that their safety is protected. The UK life sciences industry has much to offer in creating, developing, trialing and commercialising medicines that will benefit UK patients and strengthen the ability of the UK to compete internationally.</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2018-12-20T17:07:43.307Zmore like thismore than 2018-12-20T17:07:43.307Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
4488
label Biography information for Martyn Day more like this
1024713
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading General Practitioners: Standards more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of patients waiting at least three weeks to see a GP. more like this
tabling member constituency Coventry South more like this
tabling member printed
Mr Jim Cunningham more like this
uin 202044 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>The Government has committed to ensuring everyone across the country has easier and more convenient access to general practice services, including appointments in the evenings and weekends.</p><p> </p><p>The latest National Health Service planning guidance, issued by NHS England in February 2018, brought forward the deadline for clinical commissioning groups to provide extended access to general practice services to 1 October 2018, to ensure additional capacity is in place ahead of winter 2018. This includes ensuring that access is available during peak times of demand, including bank holidays and across the Easter, Christmas and New Year periods.</p><p> </p><p>NHS England and Health Education England (HEE) are working together with the profession to increase the general practitioner (GP) workforce. This includes measures to boost recruitment, address the reasons why GPs are leaving the profession, and encourage GPs to return to practice.</p><p> </p><p>The number of doctors entering GP speciality training has been increasing year on year, this year HEE recruited the highest number of GP trainees ever - 3,473 GP trainees against a target of 3,250, a 10% increase on last year.</p><p> </p><p>Greater skill mix is also key to releasing capacity in general practice, we have committed to investment in the multidisciplinary workforce in general practice. As of June 2018, there were</p><p>over 3,300 additional clinical staff, excluding GPs, working in general practice since 2015; consisting of over 500 more nurses and 2,800 more other direct patient care.</p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-12-18T17:06:19.303Zmore like thismore than 2018-12-18T17:06:19.303Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
308
label Biography information for Mr Jim Cunningham more like this
1024731
registered interest true more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Mental Health Services: Children more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the briefing published by the Children's Commissioner entitled Children’s Mental Healthcare in England published November 2018, what steps his Department is taking to reduce waiting times for children with mental health problems. more like this
tabling member constituency Barnsley Central more like this
tabling member printed
Dan Jarvis more like this
uin 202100 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>We have made an additional £1.4 billion available for children’s mental health service transformation and are on track to ensure that an additional 70,000 children and young people access community mental health services annually by 2020/21.</p><p> </p><p>We have introduced two waiting time standards for children and young people and are on track to meet both of these standards. The first aims for 95% of children (up to 19 years old) with eating disorders to receive treatment within a week for urgent cases and four weeks for routine cases. The second aims for 50% of patients of all ages experiencing a first episode of psychosis to receive treatment within two weeks of referral.</p><p> </p><p>Our Children and Young People’s Green Paper, jointly published with the Department for Education, sets out how we plan to go further. We are piloting a four-week waiting time to improve access to services and are introducing new mental health support teams. Trailblazer sites, where we plan to test our Green Paper proposals, will be announced shortly.</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2018-12-18T14:36:32.337Zmore like thismore than 2018-12-18T14:36:32.337Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
4243
label Biography information for Dan Jarvis more like this
1024775
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Doctors: Migrant Workers more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what verification checks are undertaken by his Department on the qualifications of EU citizens practicing medicine in the UK. more like this
tabling member constituency Shipley more like this
tabling member printed
Philip Davies more like this
uin 202074 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>The Department does not verify qualifications of European Union citizens practising medicine in the United Kingdom. The verification of professional qualifications is a matter for the General Medical Council (GMC) and local employers.</p><p> </p><p>The GMC is the independent regulator of doctors in the UK. All doctors must register with the GMC to be able to practise in the UK. Verification of professional qualifications is part of the GMC’s registration process.</p><p> </p><p>NHS Employers advises employing organisations to undertake professional registration and qualifications verification checks.</p> more like this
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
question first answered
less than 2018-12-18T11:43:07.853Zmore like thismore than 2018-12-18T11:43:07.853Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
1565
label Biography information for Sir Philip Davies more like this
1024776
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Doctors: Convictions more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many doctors currently working in the NHS have been convicted of (a) manslaughter, (b) clinical medical negligence or (c) culpable homicide. more like this
tabling member constituency Shipley more like this
tabling member printed
Philip Davies more like this
uin 202075 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>The Department does not hold information on convictions for doctors working in the National Health Service.</p> more like this
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
question first answered
less than 2018-12-18T14:05:09.51Zmore like thismore than 2018-12-18T14:05:09.51Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
1565
label Biography information for Sir Philip Davies more like this
1024789
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Ovarian Cancer: Staffordshire more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) increase early diagnosis rates for ovarian cancer and (b) increase access to treatment for ovarian cancer in specialist centres in Staffordshire. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly more like this
uin 202081 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>Public Health England (PHE) has run a number of ‘Be Clear on Cancer’ campaigns to help improve early detection of cancer including ovarian cancer. In 2014 PHE ran a pilot regional ovarian cancer campaign in the North West of England. In 2017, PHE ran a pilot campaign in the East and West Midlands which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer. NHS England has invested over £200 million between 2017 and 2019, supporting Cancer Alliances to accelerate diagnosis and enhance quality of life.</p><p> </p><p>Staffordshire clinical commissioning groups commission diagnostic services for ovarian cancer fully in line with National Institute for Health and Care Excellence guidelines across the whole sustainability and transformation partnership.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-12-18T17:04:54.847Zmore like thismore than 2018-12-18T17:04:54.847Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1024791
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-12-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Eating Disorders more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 December 2018 to Question 197605, whether the long-term plan for the NHS will address regional variations in access to specialist support for adults with eating disorders. more like this
tabling member constituency North Norfolk more like this
tabling member printed
Norman Lamb more like this
uin 202083 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>Mental health will be a core part of the National Health Service long-term plan, including building on the improvements in providing access to good mental health services. The NHS long-term plan is currently in development and will be published shortly by NHS England.</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2018-12-18T14:37:26.743Zmore like thismore than 2018-12-18T14:37:26.743Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1439
label Biography information for Norman Lamb more like this